natgillin/translations-raw huggingface dataset:
in the sixth column, expiration of approval, of row 7, Metsulfuron methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 7., metsulfuron-metil, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 9, Triasulfuron, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 9., triasulfuron, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 10, Esfenvalerate, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 10., esfenvalerat, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 11, Bentazone, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 11., bentazon, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 12, Lambda-cyhalothrin, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 12., lambda-cihalotrin, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 14, Amitrole, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 14., amitrol, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 15, Diquat, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 15., dikvat, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 17, Thiabendazole, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 17., tiabendazol, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 19, DPX KE 459 (flupyrsulfuron-methyl), the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 19., DPX KE 459 (flupirsulfuron-metil), datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 20, Acibenzolar-s-methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 20., acibenzolar-s-metil, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 23, Pymetrozine, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 23., pimetrozin, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 24, Pyraflufen-ethyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 24., piraflufen-etil, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 25, Glyphosate, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 25., glifosat, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 26, Thifensulfuron-methyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 26., tifensulfuron-metil, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 27, 2,4-D, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 27., 2,4-D, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 28, Isoproturon, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 28., izoproturon, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 30, Iprovalicarb, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 30., iprovalikarb, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 31, Prosulfuron, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 31., prosulfuron, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 34, Cyhalofop butyl, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 34., cihalofop butil, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 35, Famoxadone, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 35., famoksadon, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 37., metalaksil-M, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 38, Picolinafen, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’;
u šestom stupcu, prestanak odobrenja, u retku 38., pikolinafen, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”;
in the sixth column, expiration of approval, of row 39, Flumioxazine, the date of ‘31 December 2015’ is replaced by ‘30 June 2016’.
u šestom stupcu, prestanak odobrenja, u retku 39., flumioksazin, datum „31. prosinca 2015.” zamjenjuje se datumom „30. lipnja 2016.”.
Commission Regulation (EU) 2015/1886
Uredba Komisije (EU) 2015/1886
refusing to authorise certain health claims made on foods and referring to children's development and health
o uskraćivanju odobrenja za određene zdravstvene tvrdnje koje se navode na hrani, a odnose se na razvoj i zdravlje djece
Pursuant to Regulation (EC) No 1924/2006 health claims made on foods are prohibited unless they are authorised by the Commission in accordance with that Regulation and included in a list of permitted claims.
U skladu s Uredbom (EZ) br. 1924/2006 zabranjuju se zdravstvene tvrdnje koje se navode na hrani, osim ako ih je odobrila Komisija u skladu s tom Uredbom i ako su uvrštene na popis dopuštenih tvrdnji.
The national competent authority is to forward valid applications to the European Food Safety Authority (EFSA), hereinafter referred to as ‘the Authority’.
Nadležno nacionalno tijelo prosljeđuje valjane zahtjeve Europskoj agenciji za sigurnost hrane (EFSA), dalje u tekstu „Agencija”.
Following receipt of an application the Authority is to inform without delay the other Member States and the Commission thereof, and to deliver an opinion on the health claim concerned.
Nakon primitka zahtjeva Agencija o njemu bez odlaganja obavješćuje druge države članice i Komisiju te daje mišljenje o toj zdravstvenoj tvrdnji.
Following an application from Specialised Nutrition Europe (formerly European Dietetic Food Industry Association), submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to ‘non-digestible oligo- and polysaccharides including galacto-oligosaccharides, oligofructose, polyfructose and inulin' and 'increase in calcium absorption’ (Question No EFSA-Q-2008-140 [2]).
Na temelju zahtjeva udruženja Specialised Nutrition Europe (ranije European Dietetic Food Industry Association), koji je podnesen u skladu s člankom 14. stavkom 1. točkom (b) Uredbe (EZ) br. 1924/2006, zatraženo je mišljenje Agencije o zdravstvenoj tvrdnji povezanoj s „neprobavljivim oligosaharidima i polisaharidima uključujući galaktooligosaharide, oligofruktozu, polifruktozu i inulin” te „povećanom apsorpcijom kalcija” (predmet br. EFSA-Q-2008-140 [2]).
The claim proposed by the applicant was worded, inter alia, as follows: ‘With non-digestible oligo- and/or polysaccharides to stimulate calcium absorption’.
Tvrdnja koju je predložio podnositelj zahtjeva glasila je, među ostalim: „S neprobavljivim oligosaharidima i/ili polisaharidima za poticanje apsorpcije kalcija”.
On the basis of the data presented, the Authority concluded in its opinion, received by the Commission and the Member States on 19 November 2014, that a cause and effect relationship cannot be established between the consumption of ‘non-digestible oligo- and polysaccharides including galacto-oligosaccharides, oligofructose, polyfructose and inulin’ and a beneficial physiological effect.
Na temelju iznesenih podataka Agencija je u svojem mišljenju, koje su Komisija i države članice primile 19. studenoga 2014., zaključila da nije utvrđena uzročno-posljedična veza između uzimanja „neprobavljivih oligosaharida i polisaharida uključujući galaktooligosaharide, oligofruktozu, polifruktozu i inulin” i korisnog fiziološkog učinka.
In particular, the Authority considered that the food constituents ‘non-digestible oligo- and polysaccharides including galacto-oligosaccharides, oligofructose, polyfructose and inulin’ were not sufficiently characterised.
Agencija je posebno smatrala da sastavnice hrane navedene kao „neprobavljivi oligosaharidi i polisaharidi uključujući galaktooligosaharide, oligofruktozu, polifruktozu i inulin” nisu dovoljno okarakterizirane.
Following an application from Specialised Nutrition Europe, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to beta-galactosidase from Streptococcus thermophilus and reduction of gastrointestinal discomfort (Question No EFSA-Q-2008-148 [3]).
Na temelju zahtjeva udruženja Specialised Nutrition Europe, koji je podnesen u skladu s člankom 14. stavkom 1. točkom (b) Uredbe (EZ) br. 1924/2006, zatraženo je mišljenje Agencije o zdravstvenoj tvrdnji povezanoj s beta-galaktozidazom iz Streptococcus thermophilus i smanjenjem probavnih smetnji (predmet br. EFSA-Q-2008-148 [3]).
The claim proposed by the applicant was worded, inter alia, as follows: ‘Lactase for comfortable digestion’.
Tvrdnja koju je predložio podnositelj zahtjeva glasila je, među ostalim: „Laktaza za lakšu probavu”.
On the basis of the data presented, the Authority concluded in its opinion, received by the Commission and the Member States on 9 October 2014, that a cause and effect relationship had not been established between the consumption of beta-galactosidase, which is produced by Streptococcus thermophilus (subsequently inactivated) during fermentation of an infant formula, and reduction of gastrointestinal discomfort.
Na temelju iznesenih podataka Agencija je u svojem mišljenju, koje su Komisija i države članice zaprimile 9. listopada 2014., zaključila da nije utvrđena uzročno-posljedična veza između uzimanja beta-galaktozidaze koju tijekom fermentacije početne hrane za dojenčad proizvodi Streptococcus thermophilus (naknadno deaktiviran) i smanjenja probavnih smetnji.
Following an application from Specialised Nutrition Europe, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to prunes and contribution to normal bowel function (Question No EFSA-Q-2008-193 [4]).
Na temelju zahtjeva udruženja Specialised Nutrition Europe, koji je podnesen u skladu s člankom 14. stavkom 1. točkom (b) Uredbe (EZ) br. 1924/2006, zatraženo je mišljenje Agencije o zdravstvenoj tvrdnji povezanoj s djelovanjem suhih šljiva i doprinosom normalnom radu crijeva (predmet br. EFSA-Q-2008-193 [4]).
The claim proposed by the applicant was worded, inter alia, as follows: ‘dried plums/prunes can contribute to normal bowel function’.
Tvrdnja koju je predložio podnositelj zahtjeva glasila je, među ostalim: „suhe šljive mogu doprinijeti normalnom radu crijeva”.
On the basis of the data presented, the Authority concluded in its opinion, received by the Commission and the Member States on 19 November 2014, that a cause and effect relationship had not been established between the consumption of prunes and contribution to normal bowel function without the occurrence of diarrhoea for infants and young children from 6 months to 3 years of age.
Na temelju iznesenih podataka Agencija je u svojem mišljenju, koje su Komisija i države članice zaprimile 19. studenoga 2014., zaključila da nije utvrđena uzročno-posljedična veza između uzimanja suhih šljiva i doprinosa normalnom radu crijeva bez pojave proljeva kod dojenčadi i male djece od šest mjeseci do tri godine života.
In particular, the Authority noted that no studies investigating the effect of prunes on bowel function in infants and young children were provided by the applicant.
Agencija je posebno utvrdila da podnositelj zahtjeva nije dostavio nijednu studiju koja istražuje učinak suhih šljiva na rad crijeva u dojenčadi i male djece.
However, the health claims referred to in paragraph 1 used prior to the entry into force of this Regulation may continue to be used for a maximum period of 6 months after the entry into force of this Regulation.
Međutim, zdravstvene tvrdnje iz stavka 1. koje su se upotrebljavale prije stupanja na snagu ove Uredbe mogu se nastaviti upotrebljavati najviše šest mjeseci nakon stupanja na snagu ove Uredbe.
EFSA Journal 2014;12(11):3889.
EFSA Journal (2014.);12(11):3889.
EFSA Journal 2014;12(10):3841.
EFSA Journal (2014.);12(10):3841.
EFSA Journal 2014;12(11):3892.
EFSA Journal (2014.);12(11):3892.
Application — Relevant provisions of Regulation (EC) No 1924/2006
Zahtjev – Odgovarajuće odredbe Uredbe (EZ) br. 1924/2006
Non-digestible oligo- and polysaccharides including galacto-oligosaccharides, oligofructose, polyfructose and inulin
Neprobavljivi oligosaharidi i polisaharidi uključujući galaktooligosaharide, oligofruktozu, polifruktozu i inulin
With non-digestible oligo- and/or polysaccharides to stimulate calcium absorption
S neprobavljivim oligosaharidima i/ili polisaharidima za poticanje apsorpcije kalcija
Beta-galactosidase from Streptococcus thermophilus
Beta-galaktozidaza iz Streptococcus thermophilus
Lactase for comfortable digestion
Laktaza za lakšu probavu
Prunes
Suhe šljive
Dried plums/prunes can contribute to normal bowel function
Suhe šljive mogu pridonijeti normalnom radu crijeva
In accordance with Article 28(6) of Regulation (EC) No 1924/2006, health claims referred to in Article 14(1)(b) of that Regulation and not authorised by a decision pursuant to Article 17(3) of that Regulation may continue to be used for 6 months after the adoption of that decision, provided that the application for authorisation was made before 19 January 2008.
U skladu s člankom 28. stavkom 6. Uredbe (EZ) br. 1924/2006 zdravstvene tvrdnje iz njezina članka 14. stavka 1. točke (b) koje nisu odobrene odlukom u skladu s člankom 17. stavkom 3. te Uredbe mogu se nastaviti upotrebljavati šest mjeseci nakon donošenja te odluke, pod uvjetom da je zahtjev za odobrenje podnesen prije 19. siječnja 2008.
Accordingly, as the health claims listed in the Annex to this Regulation fulfil those conditions, the transitional period laid down in Article 28(6) of Regulation (EC) No 1924/2006 should apply.
Budući da zdravstvene tvrdnje navedene u Prilogu ovoj Uredbi ispunjuju navedene uvjete, trebalo bi se stoga primjenjivati prijelazno razdoblje utvrđeno u članku 28. stavku 6. Uredbe (EZ) br. 1924/2006.
Commission Implementing Regulation (EU) 2015/1887
Provedbena uredba Komisije (EU) 2015/1887
Commission Implementing Regulation (EU) 2015/1888
Provedbena uredba Komisije (EU) 2015/1888
fixing the allocation coefficient to be applied to the quantities on which applications for import licences and applications for import rights lodged from 1 to 7 October 2015 are based and establishing the quantities to be added to the quantity fixed for the sub-period from 1 April to 30 June 2016 under the tariff quotas opened by Regulation (EC) No 616/2007 for poultrymeat
o utvrđivanju koeficijenta dodjele koji se primjenjuje na količine obuhvaćene zahtjevima za uvozne dozvole i zahtjevima za uvozna prava podnesenima od 1. do 7. listopada 2015. i o određivanju količina koje je potrebno dodati količini utvrđenoj za podrazdoblje od 1. travnja do 30. lipnja 2016. u okviru carinskih kvota koje su Uredbom (EZ) br. 616/2007 otvorene u sektoru mesa peradi
The quantities on which applications for import licences lodged from 1 to 7 October 2015 for the sub-period from 1 January to 31 March 2016 are based relate, for some quotas, to quantities exceeding those available.
Količine obuhvaćene zahtjevima za uvozne dozvole podnesenima od 1. do 7. listopada 2015. za podrazdoblje od 1. siječnja do 31. ožujka 2016. za neke kvote premašuju raspoložive količine.
The quantities on which applications for import rights lodged from to 1 to 7 October 2015 for the sub-period from 1 January to 31 March 2016 are based relate, for some quotas, to quantities exceeding those available.
Količine obuhvaćene zahtjevima za uvozna prava podnesenima od 1. do 7. listopada 2015. za podrazdoblje od 1. siječnja do 31. ožujka 2016. za neke kvote premašuju raspoložive količine.
The quantities on which applications for import licences and import rights lodged from 1 to 7 October 2015 for the sub-period from 1 January to 31 March 2016 are based relate, for some quotas, to quantities less than those available.
Količine obuhvaćene zahtjevima za uvozne dozvole i zahtjevima za uvozna prava podnesenima od 1. do 7. listopada 2015. za podrazdoblje od 1. siječnja do 31. ožujka 2016. za neke su kvote manje od raspoloživih količina.
The quantities on which applications for import licences lodged pursuant to Regulation (EC) No 616/2007 for the sub-period from 1 January to 31 March 2016 are based shall be multiplied by the allocation coefficient set out in part A of the Annex hereto.
Količine obuhvaćene zahtjevima za uvozne dozvole podnesenima u skladu s Uredbom (EZ) br. 616/2007 za podrazdoblje od 1. siječnja do 31. ožujka 2016. množe se s koeficijentom dodjele iz dijela A Priloga ovoj Uredbi.
The quantities for which applications for import licences have not been lodged pursuant to Regulation (EC) No 616/2007, to be added to the sub-period from 1 April to 30 June 2016, are set out in part A of the Annex hereto.
Količine za koje nisu podneseni zahtjevi za uvozne dozvole u skladu s Uredbom (EZ) br. 616/2007, koje je potrebno dodati podrazdoblju od 1. travnja do 30. lipnja 2016., navedene su u dijelu A Priloga ovoj Uredbi.
The quantities on which applications for import rights lodged pursuant to Regulation (EC) No 616/2007 for the sub-period from 1 January to 31 March 2016 are based shall be multiplied by the allocation coefficient set out in part B of the Annex hereto.
Količine obuhvaćene zahtjevima za uvozna prava podnesenima u skladu s Uredbom (EZ) br. 616/2007 za podrazdoblje od 1. siječnja do 31. ožujka 2016. množe se s koeficijentom dodjele iz dijela B Priloga ovoj Uredbi.
The quantities for which applications for import rights have not been lodged pursuant to Regulation (EC) No 616/2007, to be added to the sub-period from 1 April to 30 June 2016, are set out in part B of the Annex hereto.
Količine za koje nisu podneseni zahtjevi za uvozna prava u skladu s Uredbom (EZ) br. 616/2007, koje je potrebno dodati podrazdoblju od 1. travnja do 30. lipnja 2016., navedene su u dijelu B Priloga ovoj Uredbi.
Allocation coefficient — applications lodged for the sub-period from 1 January to 31 March 2016
Koeficijent dodjele – zahtjevi podneseni za podrazdoblje od 1. siječnja do 31. ožujka 2016.
Non-requested quantities to be added to the quantities available for the sub-period from 1 April to 30 June 2016
Količine za koje nije podnesen zahtjev koje treba dodati količini raspoloživoj za podrazdoblje od 1. travnja do 30. lipnja 2016.
Commission Regulation (EU) 2015/1895
Uredba Komisije (EU) 2015/1895
establishing a prohibition of fishing for anglerfish in areas VIIIa, VIIIb, VIIId and VIIIe by vessels flying the flag of Belgium
o zabrani ribolova grdobine u zonama VIII.a, VIII.b, VIII.d i VIII.e za plovila koja plove pod zastavom Belgije
Commission Regulation (EU) 2015/1896
Uredba Komisije (EU) 2015/1896
establishing a prohibition of fishing for hake in areas VIIIa, VIIIb, VIIId and VIIIe by vessels flying the flag of Belgium
o zabrani ribolova oslića u zonama VIII.a, VIII.b, VIII.d i VIII.e za plovila koja plove pod zastavom Belgije
Commission Implementing Regulation (EU) 2015/1897
Provedbena uredba Komisije (EU) 2015/1897
amending Commission Regulation (EC) No 2056/2001 as regards the landing obligation
o izmjeni Uredbe (EZ) br. 2056/2001 u pogledu obveze iskrcavanja
Regulation (EU) No 1380/2013 of the European Parliament and of the Council [2] established as one of its objectives the gradual elimination of discards through the introduction of a landing obligation for catches of species subject to catch limits.
Jedan od ciljeva Uredbe (EU) br. 1380/2013 Europskog parlamenta i Vijeća [2] jest postupno uklanjanje odbačenog ulova uvođenjem obveze iskrcavanja za ulove vrsta koje podliježu ograničenjima ulova.
Certain provisions of the Commission Regulation (EC) No 2056/2001 [3] establishing additional technical measures for the recovery of the stocks of cod in the North Sea and to the west of Scotland oblige fisherman to discard fish.
Određenim odredbama Uredbe Komisije (EZ) br. 2056/2001 [3] o utvrđivanju dodatnih tehničkih mjera za obnavljanje stokova bakalara u Sjevernom moru i zapadno od Škotske ribari se obvezuju na odbacivanje ribe.
In order to remove incompatibilities between that Regulation and the landing obligation, and make the landing obligation operational, those provisions should be amended.
Kako bi se otklonile neusklađenosti između te Uredbe i obveze iskrcavanja i kako bi se obvezu iskrcavanja učinilo operativnom, te bi odredbe trebalo izmijeniti.
In particular, in order to ensure the implementation of the landing obligation, Regulation (EC) No 2056/2001 should be amended by requiring that all unintended catches of marine organisms of species subject to the landing obligation and caught in excess of the catch composition limits be landed and counted against quotas.
Konkretno, kako bi se osigurala provedba obveze iskrcavanja, Uredbu (EZ) br. 2056/2001 trebalo bi izmijeniti uvođenjem zahtjeva da se svi nenamjerni ulovi morskih organizama vrsta koje podliježu obvezi iskrcavanja i koje su ulovljene u količinama koje premašuju ograničenja sastava ulova, iskrcaju i oduzmu od kvota.
Regulation (EC) No 2056/2001 is amended as follows:
Uredba (EZ) br. 2056/2001 mijenja se kako slijedi:
in Article 2, the following point 3 is added:
U članku 2. dodaje se sljedeća točka 3.:
the following Article 9a is inserted:
Umeće se sljedeći članak 9.a:
Where marine organisms of a species subject to the landing obligation are caught in excess of permitted percentages or quantities specified in Article 4(1) to (6), Article 5(2), Article 6(2), Article 7 and Article 8 of this Regulation, Article 15 of Regulation (EU) No 1380/2013 shall apply.
Ako su morski organizmi vrste koja podliježe obvezi iskrcavanja ulovljeni u količinama koje premašuju dopuštene postotke ili količine navedene u članku 4. stavcima 1. do 6., članku 5. stavku 2., članku 6. stavku 2., članku 7. i članku 8. ove Uredbe, primjenjuje se članak 15. Uredbe (EU) br. 1380/2013.
Such unintended catches shall not be deemed to represent a breach of the permitted percentages of the catch composition specified in those Articles.’
Takvi se nenamjerni ulovi ne smatraju povredom dopuštenih postotaka sastava ulova utvrđenih u tim člancima.”